Skip to main content

Octaplas Side Effects

Generic name: plasma protein fraction

Medically reviewed by Drugs.com. Last updated on Jul 24, 2023.

Note: This document contains side effect information about plasma protein fraction. Some dosage forms listed on this page may not apply to the brand name Octaplas.

Applies to plasma protein fraction: parenteral solution for injection.

Side effects include:

Flushing, urticaria, nausea, headache, back pain.

For Healthcare Professionals

Applies to plasma protein fraction: intravenous solution.

Cardiovascular

Very rare (less than 0.01%): Cardiac arrest, arrhythmia, tachycardia, thromboembolism, hypotension, hypertension, circulatory overload, circulatory collapse, flushing

Frequency not reported: Severe hypotension, chest pain, chest discomfort[Ref]

Dermatologic

Common (1% to 10%): Urticaria, pruritus

Very rare (less than 0.01%): Rash (erythematous), hyperhidrosis[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Nausea, vomiting

Very rare (less than 0.01%): Abdominal pain[Ref]

Musculoskeletal

Very rare (less than 0.01%): Back pain[Ref]

Nervous system

Uncommon (0.1% to 1%): Hypoesthesia

Very rare (less than 0.01%): Dizziness, paresthesia

Frequency not reported: Headache[Ref]

Hematologic

Very rare (less than 0.01%): Hemolytic anemia, hemorrhagic diathesis, citrate toxicity

Frequency not reported: Hyperfibrinolysis[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Anaphylaxis

Rare (less than 0.1%): Hypersensitivity[Ref]

Local

Very rare (less than 0.01%): Application site reaction[Ref]

Metabolic

Frequency not reported: Alkalosis[Ref]

Psychiatric

Very rare (less than 0.01%): Anxiety, agitation, restlessness[Ref]

Respiratory

Uncommon (0.1% to 1%): Hypoxia

Very rare (less than 0.01%): Respiratory failure, pulmonary hemorrhage, bronchospasm, pulmonary edema, dyspnea, respiratory disorder, oxygen saturation decreased

Frequency not reported: Tachypnea[Ref]

Other

Uncommon (0.1% to 1%): Pyrexia

Very rare (less than 0.01%): Chills, localized edema, malaise, antibody test positive[Ref]

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Plasmanate (plasma protein fraction). Bayer Pharmaceutical Inc. 2013.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.